ICU Medical (NASDAQ:ICUI) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of ICU Medical (NASDAQ:ICUI) from a hold rating to a buy rating in a research report sent to investors on Friday.

Several other analysts also recently commented on the stock. Raymond James set a $97.00 price objective on shares of ICU Medical in a research report on Wednesday, March 12th. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $168.67.

ICU Medical Stock Performance

Shares of ICU Medical stock opened at $139.32 on Friday. ICU Medical has a 1-year low of $93.36 and a 1-year high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The business has a 50-day moving average price of $151.64 and a two-hundred day moving average price of $162.65. The company has a market cap of $3.42 billion, a P/E ratio of -30.49 and a beta of 0.73.

Institutional Trading of ICU Medical

Institutional investors have recently made changes to their positions in the company. Harvest Fund Management Co. Ltd bought a new position in shares of ICU Medical during the fourth quarter valued at about $33,000. Quarry LP boosted its stake in shares of ICU Medical by 764.3% in the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier’s stock worth $38,000 after buying an additional 214 shares during the last quarter. Murphy & Mullick Capital Management Corp purchased a new position in shares of ICU Medical in the 4th quarter worth approximately $52,000. Venturi Wealth Management LLC grew its holdings in shares of ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock valued at $82,000 after acquiring an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. lifted its holdings in ICU Medical by 88.8% during the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier’s stock worth $99,000 after acquiring an additional 300 shares during the period. Institutional investors own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.